Accumulating evidence indicates that RECK is down-regulated in various solid tumors and that the level of residual RECK expression in resected tumors often correlates with better prognosis, supporting the authenticity of RECK as a clinically relevant tumor suppressor [18]. This evidence concerns the gene RECK and neoplasm.